-

Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7 at 9:10 a.m. Eastern Time (E.T.)

Cowen’s 43rd Annual Health Care Conference is taking place March 6 - 8, 2023, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and innovative panel discussions hosted by members of the Cowen research team that focus on various aspects of the health care industry.

The presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Hologic, Inc.

NASDAQ:HOLX

Release Versions
$Cashtags
Hashtags

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Social Media Profiles
More News From Hologic, Inc.

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

WASHINGTON--(BUSINESS WIRE)--1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates...

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio...

Hologic Announces Financial Results for First Quarter of Fiscal 2026

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Announces Financial Results for First Quarter of Fiscal 2026...
Back to Newsroom